CClinicalTrials.gg
RecruitingNCT06169605Updated May 29, 2024

Assessment of the Effect of Tumor Thickness and Site on Level IV Cervical Lymph Nodes in Squamous Cell Carcinoma of the Tongue and Floor of the Mouth: A Case Series Study

An interventional study of removal of primary tumor, neck dissection in Tongue Neoplasms, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 15 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-29.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 4 months ago, but the record still lists the study as recruiting.
  • Started Apr 2024; still recruiting 2 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
15 Years to 60 Years
Sex
All
01

Study summary

Regarding oral cavity cancer, the high incidence of neck metastasis along with its impact on survival and prognosis are in favor of elective neck dissection. Moreover, occult metastases could develop at lower levels in the neck (levels IV-V) Regarding the tongue, the rate of skip (occult) metastasis involving unremoved level IV cervical lymph nodes in squamous cell carcinoma of the tongue ranges from 0 % - 11.4 %. However, no data is available or a correlation between the risk of level IV involvement and the affection of specific tongue subsites or a certain cutoff value of tumor thickness.

02

Conditions studied

  • Tongue Neoplasms
03

In context

Carcinoma, Squamous Cell

1,772 studies on the registry are indexed under Carcinoma, Squamous Cell; 412 are open to participants now.

This study's planned enrollment of 20 is below the median of 44 across 1,414 interventional studies indexed under Carcinoma, Squamous Cell.

Browse Carcinoma, Squamous Cell studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients with squamous cell carcinoma of the tongue and floor of the mouth.
  • Age group: from 15 to 60 years old
  • No sex predilection

Exclusion criteria

Exclusion Criteria:

  • Patients with recurrent squamous cell carcinoma of the tongue and floor of the mouth.
  • Irradiated patients or those taking chemotherapy.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Patients with squamous cell carcinoma of the tongue and floor of the mouth

    Intervention group

    Procedure: removal of primary tumor, neck dissection

Interventions

  • Procedureremoval of primary tumor, neck dissection

    removal of the primary tumor with safety margins and removal of the neck lymph node levels I, II, III and IV. histological assessment of tumor thickness and whether it is associated with positive nodes in level IV or not.

06

What researchers measure

Primary outcomes

  1. tumor thickness in mellimeters

    histological assessment of tumor thickness of the resected tumor and assessment of level IV lymph nodes

    Time frame: one week: specimens are submitted immediately after surgery

  2. Number of affected level IV cervical lymph nodes

    In each case the specimen will be assessed for level IV lymph nodes affection

    Time frame: One week : submitted immediately after surgery

Secondary outcomes

  1. affected tongue site in relation to level IV cervical lymph nodes

    histological assessment of level IV lymph nodes to determine if it is affected with tumor site on the tongue (lateral border, dorsum, ventral ....) which will be documented before surgery during examination

    Time frame: One week

07

Study locations

1 of 1 sites recruiting
  • Faculty of Dentistry, Cairo University
    Cairo, Egypt
    • Mohamed Shawky, MSc · Contact
    Recruiting
08

References and documents

Publications

  • Fakih AR, Rao RS, Borges AM, Patel AR. Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. Am J Surg. 1989 Oct;158(4):309-13. doi: 10.1016/0002-9610(89)90122-0. PubMed 2802032 ↗
  • Kligerman J, Lima RA, Soares JR, Prado L, Dias FL, Freitas EQ, Olivatto LO. Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity. Am J Surg. 1994 Nov;168(5):391-4. doi: 10.1016/s0002-9610(05)80082-0. PubMed 7977957 ↗
  • Hutchison IL, Ridout F, Cheung SMY, Shah N, Hardee P, Surwald C, Thiruchelvam J, Cheng L, Mellor TK, Brennan PA, Baldwin AJ, Shaw RJ, Halfpenny W, Danford M, Whitley S, Smith G, Bailey MW, Woodwards B, Patel M, McManners J, Chan CH, Burns A, Praveen P, Camilleri AC, Avery C, Putnam G, Jones K, Webster K, Smith WP, Edge C, McVicar I, Grew N, Hislop S, Kalavrezos N, Martin IC, Hackshaw A. Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort. Br J Cancer. 2019 Nov;121(10):827-836. doi: 10.1038/s41416-019-0587-2. Epub 2019 Oct 15. Erratum In: Br J Cancer. 2022 Mar;126(5):831. doi: 10.1038/s41416-021-01678-2. PubMed 31611612 ↗
  • Shah JP, Candela FC, Poddar AK. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer. 1990 Jul 1;66(1):109-13. doi: 10.1002/1097-0142(19900701)66:13.0.co;2-a. PubMed 2354399 ↗
  • Dias FL, Lima RA, Kligerman J, Farias TP, Soares JR, Manfro G, Sa GM. Relevance of skip metastases for squamous cell carcinoma of the oral tongue and the floor of the mouth. Otolaryngol Head Neck Surg. 2006 Mar;134(3):460-5. doi: 10.1016/j.otohns.2005.09.025. PubMed 16500445 ↗
  • Matos LL, Manfro G, Santos RV, Stabenow E, Mello ES, Alves VA, Pinto FR, Kulcsar MA, Brandao LG, Cernea CR. Tumor thickness as a predictive factor of lymph node metastasis and disease recurrence in T1N0 and T2N0 squamous cell carcinoma of the oral tongue. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Aug;118(2):209-17. doi: 10.1016/j.oooo.2014.03.023. Epub 2014 Apr 12. PubMed 24906946 ↗

Individual participant data

Plan to share: Yes — will be available upon reasonable request

Supporting information: Study protocol, Sap

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06169605
Lead sponsor
Cairo University
Responsible party
Mohamed Shawky (Assistant lecturer, Cairo University) — Principal investigator
First posted
Dec 13, 2023
Start date
Apr 1, 2024
Primary completion
May 30, 2025 (estimated)
Completion
May 30, 2025 (estimated)
Last update
May 29, 2024

Study contacts

Mohamed Shawky, MSc
Contact
m.shawky1993@gmail.com
+201223933897
Mohamed Shawky, MSc
principal investigator · Cairo University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion